Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2026-06-23 16:16:29 ET · period of report 2026-06-21 · accession 0001434647-26-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-23 16:16 | 2026-06-21 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | M - OptEx | — | +66.7K | 114.8K | +139% | — |
| DT | 2026-06-23 16:16 | 2026-06-22 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | S - Sale+OE | $12.68 | -34.6K | 80.2K | -30% | -$438.3K |
| DT | 2026-06-23 16:16 | 2026-06-21 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | M - OptEx | $0.00 | -66.7K | 66.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-21 | M | A | 66,667 | — | 114,792 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-06-22 | S | D | 34,557 | $12.68 | 80,235 | D | — | — | (F2) Adoption date of referenced 10b5-1(c) plan is: 01-08-2026. (F3) This transaction was executed in multiple trades at prices ranging from $12.53 to $13.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Restricted Stock Unit | 2026-06-21 | M | D | 66,667 | $0.00 | 66,667 | D | — · — to — | 66,667 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date. (F4) The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date. |